Early detection of side effects in patients with metastatic melanoma receiving immune checkpoint inhibitors by investigation of CD8+ immune infiltrate with [89Zr] crefmirmlimab berdoxam
We use cookies to personalize content and ads, and to analyze our traffic and improve our service. Our website uses cookies to remember you and distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site.